These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Lentiviral vector-mediated siRNA knockdown of SR-PSOX inhibits foam cell formation in vitro. Zhang L; Liu HJ; Li TJ; Yang Y; Guo XL; Wu MC; Rui YC; Wei LX Acta Pharmacol Sin; 2008 Jul; 29(7):847-52. PubMed ID: 18565283 [TBL] [Abstract][Full Text] [Related]
3. Chemokine SR-PSOX/CXCL16 expression in peripheral blood of patients with acute coronary syndrome. Yang HL; Xu YY; DU LF; Liu CH; Zhao Q; Wei WJ; You Y; Quan ZH Chin Med J (Engl); 2008 Jan; 121(2):112-7. PubMed ID: 18272035 [TBL] [Abstract][Full Text] [Related]
4. CXCL16/SR-PSOX is an interferon-gamma-regulated chemokine and scavenger receptor expressed in atherosclerotic lesions. Wuttge DM; Zhou X; Sheikine Y; Wågsäter D; Stemme V; Hedin U; Stemme S; Hansson GK; Sirsjö A Arterioscler Thromb Vasc Biol; 2004 Apr; 24(4):750-5. PubMed ID: 14988089 [TBL] [Abstract][Full Text] [Related]
6. The chemokine and scavenger receptor CXCL16/SR-PSOX is expressed in human vascular smooth muscle cells and is induced by interferon gamma. Wågsäter D; Olofsson PS; Norgren L; Stenberg B; Sirsjö A Biochem Biophys Res Commun; 2004 Dec; 325(4):1187-93. PubMed ID: 15555552 [TBL] [Abstract][Full Text] [Related]
7. Distribution and kinetics of SR-PSOX/CXCL16 and CXCR6 expression on human dendritic cell subsets and CD4+ T cells. Tabata S; Kadowaki N; Kitawaki T; Shimaoka T; Yonehara S; Yoshie O; Uchiyama T J Leukoc Biol; 2005 May; 77(5):777-86. PubMed ID: 15703197 [TBL] [Abstract][Full Text] [Related]
8. Upregulation of SR-PSOX/CXCL16 and recruitment of CD8+ T cells in cardiac valves during inflammatory valvular heart disease. Yamauchi R; Tanaka M; Kume N; Minami M; Kawamoto T; Togi K; Shimaoka T; Takahashi S; Yamaguchi J; Nishina T; Kitaichi M; Komeda M; Manabe T; Yonehara S; Kita T Arterioscler Thromb Vasc Biol; 2004 Feb; 24(2):282-7. PubMed ID: 14699018 [TBL] [Abstract][Full Text] [Related]
9. High levels and inflammatory effects of soluble CXC ligand 16 (CXCL16) in coronary artery disease: down-regulatory effects of statins. Smith C; Halvorsen B; Otterdal K; Waehre T; Yndestad A; Fevang B; Sandberg WJ; Breland UM; Frøland SS; Oie E; Gullestad L; Damås JK; Aukrust P Cardiovasc Res; 2008 Jul; 79(1):195-203. PubMed ID: 18339644 [TBL] [Abstract][Full Text] [Related]
10. CXC chemokine ligand 16 in periodontal diseases: expression in diseased tissues and production by cytokine-stimulated human gingival fibroblasts. Hosokawa Y; Hosokawa I; Ozaki K; Nakae H; Matsuo T Clin Exp Immunol; 2007 Jul; 149(1):146-54. PubMed ID: 17459077 [TBL] [Abstract][Full Text] [Related]
11. Effects of all-trans retinoic acid and interferon-gamma on expression of RAR beta gene in Tca8113 cells. Chen WT; He RG; Liu XK; Zhou XJ Chin J Dent Res; 1999 Dec; 2(3-4):25-30. PubMed ID: 10863413 [TBL] [Abstract][Full Text] [Related]
12. CXCL16 functions as a novel chemotactic factor for prostate cancer cells in vitro. Lu Y; Wang J; Xu Y; Koch AE; Cai Z; Chen X; Galson DL; Taichman RS; Zhang J Mol Cancer Res; 2008 Apr; 6(4):546-54. PubMed ID: 18344492 [TBL] [Abstract][Full Text] [Related]
13. Expression and potential function of the CXC chemokine CXCL16 in pancreatic ductal adenocarcinoma. Wente MN; Gaida MM; Mayer C; Michalski CW; Haag N; Giese T; Felix K; Bergmann F; Giese NA; Friess H Int J Oncol; 2008 Aug; 33(2):297-308. PubMed ID: 18636150 [TBL] [Abstract][Full Text] [Related]
14. SR-PSOX at sites predisposed to atherosclerotic lesion formation mediates monocyte-endothelial cell adhesion. Hofnagel O; Engel T; Severs NJ; Robenek H; Buers I Atherosclerosis; 2011 Aug; 217(2):371-8. PubMed ID: 21612780 [TBL] [Abstract][Full Text] [Related]
15. Regulation of CXCL16 expression and secretion by myeloid cells is not altered in rheumatoid arthritis. van Lieshout AW; van der Voort R; Toonen LW; van Helden SF; Figdor CG; van Riel PL; Radstake TR; Adema GJ Ann Rheum Dis; 2009 Jun; 68(6):1036-43. PubMed ID: 18628285 [TBL] [Abstract][Full Text] [Related]
16. Overexpression of CXCL16 and its receptor CXCR6/Bonzo promotes growth of human schwannomas. Held-Feindt J; Rehmke B; Mentlein R; Hattermann K; Knerlich F; Hugo HH; Ludwig A; Mehdorn HM Glia; 2008 May; 56(7):764-74. PubMed ID: 18293410 [TBL] [Abstract][Full Text] [Related]
17. CXCL16 is a novel mediator of the innate immunity of epidermal keratinocytes. Tohyama M; Sayama K; Komatsuzawa H; Hanakawa Y; Shirakata Y; Dai X; Yang L; Tokumaru S; Nagai H; Hirakawa S; Sugai M; Hashimoto K Int Immunol; 2007 Sep; 19(9):1095-102. PubMed ID: 17855433 [TBL] [Abstract][Full Text] [Related]
18. SR-PSOX/CXCL16 plays a critical role in the progression of colonic inflammation. Uza N; Nakase H; Yamamoto S; Yoshino T; Takeda Y; Ueno S; Inoue S; Mikami S; Matsuura M; Shimaoka T; Kume N; Minami M; Yonehara S; Ikeuchi H; Chiba T Gut; 2011 Nov; 60(11):1494-505. PubMed ID: 21471570 [TBL] [Abstract][Full Text] [Related]
19. Antitumor activity of the retinoid-related molecules (E)-3-(4'-hydroxy-3'-adamantylbiphenyl-4-yl)acrylic acid (ST1926) and 6-[3-(1-adamantyl)-4-hydroxyphenyl]-2-naphthalene carboxylic acid (CD437) in F9 teratocarcinoma: Role of retinoic acid receptor gamma and retinoid-independent pathways. Parrella E; Giannì M; Fratelli M; Barzago MM; Raska I; Diomede L; Kurosaki M; Pisano C; Carminati P; Merlini L; Dallavalle S; Tavecchio M; Rochette-Egly C; Terao M; Garattini E Mol Pharmacol; 2006 Sep; 70(3):909-24. PubMed ID: 16788091 [TBL] [Abstract][Full Text] [Related]
20. Induction of CXC and CC chemokines by all-trans retinoic acid in acute promyelocytic leukemia cells. Shibakura M; Niiya K; Niiya M; Asaumi N; Yoshida C; Nakata Y; Tanimoto M Leuk Res; 2005 Jul; 29(7):755-9. PubMed ID: 15927671 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]